Posted on by Pencis

Reigner Jay Escartin | HIV-1 | Best Researcher Award

Mr. Reigner Jay Escartin , University of the Immaculate Conception, Philippines.

Mr. Reigner Jay Escartin is an accomplished researcher specializing in HIV-1 studies. His groundbreaking work has significantly advanced the understanding of the virus, focusing on treatment strategies and viral pathogenesis. His dedication to HIV research has earned him the prestigious Best Researcher Award, recognizing his contributions to global health and scientific innovation. Escartin’s research continues to impact the fight against HIV/AIDS, with a commitment to improving patient outcomes and advancing therapeutic approaches.

Profile:

Orcid  Profile

Education and Experience

Mr. Reigner Jay Escartin holds a Bachelor of Science in Medical Technology/Medical Laboratory Science from the University of the Immaculate Conception. He completed his Medical Technology internship at Davao Doctors Hospital (2022–2023) and is currently pursuing a Master of Science in Medical Technology, majoring in Biomedical Sciences (2023–present). Mr. Escartin serves as a full-time faculty member and clinical instructor at his alma mater. He is a registered member of PAMET, PAPSI, and the Philippine Association of Schools of Medical Technology and Public Health, Inc. Additionally, he holds a Lean Six Sigma White Belt certification, reflecting his commitment to continuous improvement in the field.

 

Areas of Research

Mr. Reigner Jay Escartin’s primary research area focuses on HIV-1, with a notable contribution to understanding the success rates and adherence to antiretroviral therapy (ART) among treatment-naïve patients in Davao City, Philippines. His work is highlighted by a ten-year retrospective cohort study that examined the long-term effectiveness of ART, analyzing patient adherence and identifying key factors that influence treatment outcomes. Through this research, Mr. Escartin has contributed valuable insights into the challenges faced by HIV-1 patients in adhering to therapy, particularly within local contexts. His findings aim to improve healthcare delivery and patient support systems, ultimately enhancing the quality of life for individuals living with HIV. Although still early in his career, his commitment to research and innovation in HIV-1 therapy provides a foundation for future development and collaboration in both clinical and public health settings. By addressing real-world issues in HIV treatment, his work is poised to drive further research and extension activities that could have a lasting impact on patient care and treatment protocols in the region.

Research and Innovations

Mr. Reigner Jay Escartin has completed one ongoing research project, though he currently has no consultancy or industry-sponsored projects, and the total cost of his projects is not applicable. He has published one journal article indexed in Scopus, Web of Science, or PubMed, but has no publications in SCI or SCIE indexes. He has not yet published any books, chapters, or conference proceedings, nor has he filed any patents. Additionally, he holds no editorial appointments in journals or conferences and has no citation index, H-index, or cumulative impact factor in the past three years. He has not presented at conferences, served as an invited speaker or resource person, or organized any research conferences or workshops. Mr. Escartin has not visited other countries for research, has not graduated any research scholars, and has no ongoing scholars under his supervision. He is also not involved in collaborative research activities, holds no awards or recognitions, and has not established functional MoUs with other institutions or industries. Lastly, he is not a member of any professional bodies.

Top Note Publications

Escartin, R. J. (2024, December). Success rates and adherence to antiretroviral therapy among treatment-naïve patients in Davao City, Philippines: A ten-year retrospective cohort study. Dialogues in Health, ISSN 2772-6533. https://doi.org/10.1016/j.dialog.2024.100195

Reigner Jay Escartin | HIV-1 | Best Researcher Award-duplicate-1

You May Also Like